Consensus definition and diagnostic criteria for neonatal encephalopathy-study protocol for a real-time modified delphi study.


Journal

Pediatric research
ISSN: 1530-0447
Titre abrégé: Pediatr Res
Pays: United States
ID NLM: 0100714

Informations de publication

Date de publication:
20 Jun 2024
Historique:
received: 11 08 2023
accepted: 23 05 2024
revised: 06 05 2024
medline: 21 6 2024
pubmed: 21 6 2024
entrez: 20 6 2024
Statut: aheadofprint

Résumé

'Neonatal encephalopathy' (NE) describes a group of conditions in term infants presenting in the earliest days after birth with disturbed neurological function of cerebral origin. NE is aetiologically heterogenous; one cause is peripartum hypoxic ischaemia. Lack of uniformity in the terminology used to describe NE and its diagnostic criteria creates difficulty in the design and interpretation of research and complicates communication with families. The DEFINE study aims to use a modified Delphi approach to form a consensus definition for NE, and diagnostic criteria. Directed by an international steering group, we will conduct a systematic review of the literature to assess the terminology used in trials of NE, and with their guidance perform an online Real-time Delphi survey to develop a consensus diagnosis and criteria for NE. A consensus meeting will be held to agree on the final terminology and criteria, and the outcome disseminated widely. A clear and consistent consensus-based definition of NE and criteria for its diagnosis, achieved by use of a modified Delphi technique, will enable more comparability of research results and improved communication among professionals and with families. The terms Neonatal Encephalopathy and Hypoxic Ischaemic Encephalopathy tend to be used interchangeably in the literature to describe a term newborn with signs of encephalopathy at birth. This creates difficulty in communication with families and carers, and between medical professionals and researchers, as well as creating difficulty with performance of research. The DEFINE project will use a Real-time Delphi approach to create a consensus definition for the term 'Neonatal Encephalopathy'. A definition formed by this consensus approach will be accepted and utilised by the neonatal community to improve research, outcomes, and parental experience.

Sections du résumé

BACKGROUND BACKGROUND
'Neonatal encephalopathy' (NE) describes a group of conditions in term infants presenting in the earliest days after birth with disturbed neurological function of cerebral origin. NE is aetiologically heterogenous; one cause is peripartum hypoxic ischaemia. Lack of uniformity in the terminology used to describe NE and its diagnostic criteria creates difficulty in the design and interpretation of research and complicates communication with families. The DEFINE study aims to use a modified Delphi approach to form a consensus definition for NE, and diagnostic criteria.
METHODS METHODS
Directed by an international steering group, we will conduct a systematic review of the literature to assess the terminology used in trials of NE, and with their guidance perform an online Real-time Delphi survey to develop a consensus diagnosis and criteria for NE. A consensus meeting will be held to agree on the final terminology and criteria, and the outcome disseminated widely.
DISCUSSION CONCLUSIONS
A clear and consistent consensus-based definition of NE and criteria for its diagnosis, achieved by use of a modified Delphi technique, will enable more comparability of research results and improved communication among professionals and with families.
IMPACT CONCLUSIONS
The terms Neonatal Encephalopathy and Hypoxic Ischaemic Encephalopathy tend to be used interchangeably in the literature to describe a term newborn with signs of encephalopathy at birth. This creates difficulty in communication with families and carers, and between medical professionals and researchers, as well as creating difficulty with performance of research. The DEFINE project will use a Real-time Delphi approach to create a consensus definition for the term 'Neonatal Encephalopathy'. A definition formed by this consensus approach will be accepted and utilised by the neonatal community to improve research, outcomes, and parental experience.

Identifiants

pubmed: 38902453
doi: 10.1038/s41390-024-03303-3
pii: 10.1038/s41390-024-03303-3
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© 2024. The Author(s).

Références

Aslam, S., Strickland, T. & Molloy, E. J. Neonatal encephalopathy: Need for recognition of multiple etiologies for optimal management. Front Pediatr. 7, 142 (2019).
doi: 10.3389/fped.2019.00142 pubmed: 31058120 pmcid: 6477286
Executive Summary: Neonatal Encephalopathy and Neurologic Outcome, Second Edition. Report of the american college of obstetricians and gynecologists’ task force on neonatal encephalopathy. Obstet. Gynecol. 123, 896–901 (2014).
Jacobs, S. E. et al. Cooling for newborns with hypoxic ischaemic encephalopathy. Cochrane Database Syst. Rev. 2013, Cd003311 (2013).
pubmed: 23440789 pmcid: 7003568
Shankaran, S. et al. Whole-body hypothermia for neonates with hypoxic-ischemic encephalopathy. N. Engl. J. Med. 353, 1574–1584 (2005).
doi: 10.1056/NEJMcps050929 pubmed: 16221780
Gluckman, P. D. et al. Selective head cooling with mild systemic hypothermia after neonatal encephalopathy: Multicentre randomised trial. Lancet 365, 663–670 (2005).
doi: 10.1016/S0140-6736(05)17946-X pubmed: 15721471
Azzopardi, D. V. et al. Moderate hypothermia to treat perinatal asphyxial encephalopathy. N. Engl. J. Med. 361, 1349–1358 (2009).
doi: 10.1056/NEJMoa0900854 pubmed: 19797281
Laptook, A. et al. Elevated temperature after hypoxic-ischemic encephalopathy: Risk factor for adverse outcomes. Pediatrics 122, 491–499 (2008).
doi: 10.1542/peds.2007-1673 pubmed: 18762517
Laptook, A. R. et al. Elevated temperature and 6- to 7-year outcome of neonatal encephalopathy. Ann. Neurol. 73, 520–528 (2013).
doi: 10.1002/ana.23843 pubmed: 23595408 pmcid: 3720800
Thayyil, S. et al. Hypothermia for moderate or severe neonatal encephalopathy in low-income and middle-income countries (Helix): A randomised controlled trial in India, Sri Lanka, and Bangladesh. Lancet Glob. Health 9, e1273–e1285 (2021).
doi: 10.1016/S2214-109X(21)00264-3 pubmed: 34358491 pmcid: 8371331
Wu, Y. W. et al. Trial of erythropoietin for hypoxic-ischemic encephalopathy in newborns. N. Engl. J. Med. 387, 148–159 (2022).
doi: 10.1056/NEJMoa2119660 pubmed: 35830641 pmcid: 10542745
Morell, A. S. et al. Genetic and congenital anomalies in infants with hypoxic-ischemic encephalopathy. Pediatr. Neurol. 154, 44–50 (2024).
doi: 10.1016/j.pediatrneurol.2024.02.007 pubmed: 38518503
Martinello, K., Hart, A. R., Yap, S., Mitra, S. & Robertson, N. J. Management and investigation of neonatal encephalopathy: 2017 update. Arch. Dis. Child Fetal Neonatal Ed. 102, F346–f358 (2017).
doi: 10.1136/archdischild-2015-309639 pubmed: 28389438
Nelson, K. B. et al. Antecedents of neonatal encephalopathy in the vermont oxford network encephalopathy registry. Pediatrics 130, 878–886 (2012).
doi: 10.1542/peds.2012-0714 pubmed: 23071210 pmcid: 4074646
Felix, J. F. et al. Birth defects in children with newborn encephalopathy. Dev. Med. Child Neurol. 42, 803–808 (2000).
doi: 10.1111/j.1469-8749.2000.tb00693.x pubmed: 11132253
Chalak, L., Ferriero, D. M., Gressens, P., Molloy, E. & Bearer, C. A 20 years conundrum of neonatal encephalopathy and hypoxic ischemic encephalopathy: Are we closer to a consensus guideline? Pediatr. Res 86, 548–549 (2019).
doi: 10.1038/s41390-019-0547-9 pubmed: 31450231
Molloy, E. J. & Bearer, C. Neonatal encephalopathy versus hypoxic-ischemic encephalopathy. Pediatr. Res. 84, 574 (2018).
doi: 10.1038/s41390-018-0169-7 pubmed: 30214023
Chalak, L. F. et al. Prospective research in infants with mild encephalopathy identified in the first six hours of life: neurodevelopmental outcomes at 18-22 months. Pediatr. Res. 84, 861–868 (2018).
doi: 10.1038/s41390-018-0174-x pubmed: 30250303 pmcid: 6445543
Finder, M. et al. Two-year neurodevelopmental outcomes after mild hypoxic ischemic encephalopathy in the era of therapeutic hypothermia. JAMA Pediatr. 174, 48–55 (2020).
doi: 10.1001/jamapediatrics.2019.4011 pubmed: 31710357
Thayyil, S. et al. Whole-body hypothermia, cerebral magnetic resonance biomarkers, and outcomes in neonates with moderate or severe hypoxic-ischemic encephalopathy born at tertiary care centers vs other facilities: a nested study within a randomized clinical trial. JAMA Netw. Open 6, e2312152 (2023).
doi: 10.1001/jamanetworkopen.2023.12152 pubmed: 37155168 pmcid: 10167567
Shankaran, S. et al. Effect of depth and duration of cooling on death or disability at age 18 months among neonates with hypoxic-ischemic encephalopathy: A randomized clinical trial. JAMA 318, 57–67 (2017).
doi: 10.1001/jama.2017.7218 pubmed: 28672318 pmcid: 5793705
Jacobs, S. E. et al. Whole-body hypothermia for term and near-term newborns with hypoxic-ischemic encephalopathy: A randomized controlled trial. Arch. Pediatr. Adolesc. Med. 165, 692–700 (2011).
doi: 10.1001/archpediatrics.2011.43 pubmed: 21464374
Simbruner, G., Mittal, R. A., Rohlmann, F. & Muche, R. Systemic hypothermia after neonatal encephalopathy: Outcomes of Neo.Neuro.Network Rct. Pediatr. 126, e771–e778 (2010).
doi: 10.1542/peds.2009-2441
Gattrell, W. T. et al. Accord guideline for reporting consensus-based methods in biomedical research and clinical practice: A Study Protocol. Res. Integr. Peer Rev. 7, 3 (2022).
doi: 10.1186/s41073-022-00122-0 pubmed: 35672782 pmcid: 9171734
Quirke, F. A. et al. Cohesion: Core outcomes in neonatal encephalopathy (protocol). Trials 22, 125 (2021).
doi: 10.1186/s13063-021-05030-0 pubmed: 33557892 pmcid: 7871638
Allen, J., Brenner, M., Hauer, J., Molloy, E. & McDonald, D. Severe neurological impairment: A delphi consensus-based definition. Eur. J. Paediatr. Neurol. 29, 81–86 (2020).
doi: 10.1016/j.ejpn.2020.09.001 pubmed: 32951992
Swedo, S. E. et al. Consensus definition of misophonia: A delphi study. Front Neurosci. 16, 841816 (2022).
doi: 10.3389/fnins.2022.841816 pubmed: 35368272 pmcid: 8969743
Turoff, M. The design of a policy delphi. Technol. Forecast. Soc. Change 2, 149–171 (1970).
doi: 10.1016/0040-1625(70)90161-7
Gordon, T. & Pease, A. Rt delphi: An efficient, “Round-Less” almost real time delphi method. Technol. Forecasting Soc. Change 73, 321–333 (2006).
doi: 10.1016/j.techfore.2005.09.005
Garner, B. R. et al. The prevalence and negative impacts of substance use disorders among people with Hiv in the United States: A real-time Delphi survey of key stakeholders. AIDS Behav. 26, 1183–1196 (2022).
doi: 10.1007/s10461-021-03473-9 pubmed: 34586532
Nabergoj Makovec, U. et al. Developing a medication adherence technologies repository: Proposed structure and protocol for an online real-time Delphi study. BMJ Open 12, e059674 (2022).
doi: 10.1136/bmjopen-2021-059674 pubmed: 35459677 pmcid: 9074304
Quirke, F. A. et al. Multi-round versus real-time delphi survey approach for achieving consensus in the cohesion core outcome set: A randomised trial. Trials 24, 461 (2023).
doi: 10.1186/s13063-023-07388-9 pubmed: 37468987 pmcid: 10354951
Quirke, F. A. et al. Multi-round compared to real-time delphi for consensus in core outcome set (Cos) development: A randomised trial. Trials 22, 142 (2021).
doi: 10.1186/s13063-021-05074-2 pubmed: 33588938 pmcid: 7885346
Varndell, W., Fry, M. & Elliott, D. Applying real-time delphi methods: Development of a pain management survey in emergency nursing. BMC Nurs. 20, 149 (2021).
doi: 10.1186/s12912-021-00661-9 pubmed: 34407815 pmcid: 8371887
Aengenheyster, S. et al. Real-time delphi in practice — a comparative analysis of existing software-based tools. Technol. Forecast. Soc. Change 118, 15–27 (2017).
doi: 10.1016/j.techfore.2017.01.023
Brookes, S. T., Chalmers, K. A., Avery, K. N. L., Coulman, K. & Blazeby, J. M. Impact of question order on prioritisation of outcomes in the development of a core outcome set: A randomised controlled trial. Trials 19, 66 (2018).
doi: 10.1186/s13063-017-2405-6 pubmed: 29370827 pmcid: 5784591
Lynn, M. R. Determination and quantification of content validity. Nurs. Res. 35, 382–385 (1986).
doi: 10.1097/00006199-198611000-00017 pubmed: 3640358
Research, C. I. O. H. Guide to Knowledge Translation Planning at Cihr: Integrated and End-of-Grant Approaches, 2012).
Dewey, M. et al. Clinical quantitative cardiac imaging for the assessment of myocardial ischaemia. Nat. Rev. Cardiol. 17, 427–450 (2020).
doi: 10.1038/s41569-020-0341-8 pubmed: 32094693 pmcid: 7297668

Auteurs

Aoife Branagan (A)

Discipline of Paediatrics, Trinity College Dublin, the University of Dublin, Dublin, Ireland.
Trinity Translational Medicine Institute (TTMI), St James Hospital & Trinity Research in Childhood Centre (TRiCC), Dublin, Ireland.
Neonatology, The Coombe Hospital, Dublin, Ireland.
Health Research Board Neonatal Encephalopathy PhD Training Network (NEPTuNE), Dublin, Ireland.

Tim Hurley (T)

Discipline of Paediatrics, Trinity College Dublin, the University of Dublin, Dublin, Ireland.
Trinity Translational Medicine Institute (TTMI), St James Hospital & Trinity Research in Childhood Centre (TRiCC), Dublin, Ireland.
Health Research Board Neonatal Encephalopathy PhD Training Network (NEPTuNE), Dublin, Ireland.

Fiona Quirke (F)

Health Research Board Neonatal Encephalopathy PhD Training Network (NEPTuNE), Dublin, Ireland.
Health Research Board-Trials Methodology, Research Network (HRB-TMRN), University of Galway, Galway, Ireland.

Declan Devane (D)

Health Research Board-Trials Methodology, Research Network (HRB-TMRN), University of Galway, Galway, Ireland.
School of Nursing and Midwifery, University of Galway, Galway, Ireland.
Evidence Synthesis Ireland, University of Galway, Galway, Ireland.
Cochrane Ireland, University of Galway, Galway, Ireland.

Petek E Taneri (PE)

Health Research Board-Trials Methodology, Research Network (HRB-TMRN), University of Galway, Galway, Ireland.
School of Nursing and Midwifery, University of Galway, Galway, Ireland.

Nadia Badawi (N)

Cerebral Palsy Alliance Research Institute, Specialty of Child & Adolescent Health, Sydney Medical School, Faculty of Medicine & Health, The University of Sydney, Sydney, NSW, Australia.
Grace Centre for Newborn Intensive Care, Sydney Children's Hospital Network, The University of Sydney, Westmead, NSW, Australia.

Bharati Sinha (B)

Department of Pediatrics, Boston Medical Center, Boston, MA, USA.

Cynthia Bearer (C)

Division of Neonatology, Department of Pediatrics, Rainbow Babies & Children's Hospital, Cleveland, OH, USA.
Case Western Reserve University School of Medicine, Cleveland, OH, USA.

Frank H Bloomfield (FH)

Liggins Institute, University of Auckland, Auckland, New Zealand.

Sonia L Bonifacio (SL)

Division of Neonatal and Developmental Medicine, Department of Pediatrics, Stanford University School of Medicine, Palo Alto, CA, USA.

Geraldine Boylan (G)

INFANT Research Centre, Cork, Ireland.
Department of Pediatrics and Child Health, University College Cork, Cork, Ireland.

Suzann K Campbell (SK)

Department of Physical Therapy, College of Applied Health Sciences, University of Illinois at Chicago, Chicago, IL, USA.

Lina Chalak (L)

Division of Neonatal-Perinatal Medicine, University of Texas Southwestern Medical Center, Dallas, TX, USA.

Mary D'Alton (M)

Department of Obstetrics and Gynecology, Columbia University, New York, NY, USA.

Linda S deVries (LS)

Department of Neonatology, Wilhelmina Children's Hospital, University Medical Center Utrecht, Utrecht, the Netherlands.

Mohamed El Dib (M)

Division of Newborn Medicine, Department of Pediatrics, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.

Donna M Ferriero (DM)

Departments of Neurology and Pediatrics, Weill Institute for Neurosciences, University of California San Francisco, San Francisco, CA, USA.

Chris Gale (C)

Neonatal Medicine, School of Public Health, Faculty of Medicine, Chelsea and Westminster Campus, Imperial College London, London, UK.

Pierre Gressens (P)

Université Paris Cité, Inserm, NeuroDiderot, 75019, Paris, France.

Alistair J Gunn (AJ)

Departments of Physiology and Paediatrics, School of Medical Sciences, University of Auckland, Auckland, New Zealand.

Sarah Kay (S)

PEEPS-HIE, Manchester, UK.

Beccy Maeso (B)

James Lind Alliance, School of Healthcare Enterprise and Innovation, University of Southampton, Southampton, UK.

Sarah B Mulkey (SB)

Children's National Hospital, Washington, DC, USA.
Departments of Neurology and Pediatrics, The George Washington University School of Medicine and Health Sciences, Washington, DC, USA.

Deirdre M Murray (DM)

INFANT Research Centre, Cork, Ireland.
Department of Pediatrics and Child Health, University College Cork, Cork, Ireland.

Karin B Nelson (KB)

National Institutes of Health, National Institute of Neurological Diseases and Stroke, Bethesda, MD, USA.

Tetyana H Nesterenko (TH)

Department of Neonatology, Cleveland Clinic Children's Hospital, Cleveland, OH, USA.

Betsy Pilon (B)

Hope for HIE, West Bloomfield, MI, USA.

Nicola J Robertson (NJ)

Institute for Women's Health, University College London, London, UK.
Centre for Clinical Brain Sciences, University of Edinburgh, Edinburgh, UK.

Karen Walker (K)

Department of Newborn Care, Royal Prince Alfred Hospital, Sydney, Local Health District, Sydney, Australia.
Faculty of Medicine and Health, University of Sydney, Sydney, Australia.

Courtney J Wusthoff (CJ)

Division of Child Neurology, Stanford University, Palo Alto, CA, USA.

Eleanor J Molloy (EJ)

Discipline of Paediatrics, Trinity College Dublin, the University of Dublin, Dublin, Ireland. Eleanor.molloy@tcd.ie.
Trinity Translational Medicine Institute (TTMI), St James Hospital & Trinity Research in Childhood Centre (TRiCC), Dublin, Ireland. Eleanor.molloy@tcd.ie.
Neonatology, The Coombe Hospital, Dublin, Ireland. Eleanor.molloy@tcd.ie.
Health Research Board Neonatal Encephalopathy PhD Training Network (NEPTuNE), Dublin, Ireland. Eleanor.molloy@tcd.ie.
Neonatology, Children's Health Ireland, Dublin, Ireland. Eleanor.molloy@tcd.ie.
Neurodisability, Children's Hospital Ireland (CHI) at Tallaght, Dublin, Ireland. Eleanor.molloy@tcd.ie.

Classifications MeSH